Our Mission

The National Bleeding Disorders Foundation (NBDF) Nebraska Chapter is dedicated to finding cures for inheritable blood disorders and addressing and preventing the complications of these disorders through research, education, and advocacy enabling people and families to thrive.

News Articles

In a May 27th letter to the hemophilia community, it was confirmed that Spark Therapeutics has been fully integrated into the Roche Group. Spark first became a member of the Roche Group in 2019 with the aim of continuing to advance potential gene therapies for hemophilia and many other genetic diseases.

Keri Norris, PhD, JM, MPH, MCHES, Senior Vice President, Health Access and Strategic Innovation, of the National Bleeding Disorders Foundation is a Fierce DEI Award Finalist in the Leadership in Health Equity Category

Dr. Norris has been recognized for her transformative work advancing health access in the inheritable blood and bleeding disorders community.

ADVERTISEMENTS

.

8031 West Center Road
Suite 301
Omaha, NE 68124

© National Bleeding Disorders Foundation 2025

Crafted by Firespring